{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:23:50Z","timestamp":1762867430623,"version":"3.41.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Health System Research Institute","award":["P-13-50112"],"award-info":[{"award-number":["P-13-50112"]}]},{"name":"Phramongkutklao Research Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12936-018-2347-9","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T08:11:59Z","timestamp":1526371919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project"],"prefix":"10.1186","volume":"17","author":[{"given":"Thunyapit","family":"Thita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimrat","family":"Jadsri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarupatr","family":"Thamkhantho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toon","family":"Ruang-areerate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nantana","family":"Suwandittakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruemon","family":"Sitthichot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittiya","family":"Mahotorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peerapan","family":"Tan-ariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathirut","family":"Mungthin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"2347_CR1","doi-asserted-by":"publisher","DOI":"10.30875\/ac42f7b8-en","volume-title":"World malaria report 2012","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. World malaria report 2012. Geneva: World Health Organization; 2012."},{"key":"2347_CR2","volume-title":"Global report on antimalarial drug efficacy and drug resistance 2000\u20132010","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Global report on antimalarial drug efficacy and drug resistance 2000\u20132010. Geneva: World Health Organization; 2010."},{"key":"2347_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-3156.2005.01557.x","volume":"11","author":"S Vijaykadga","year":"2006","unstructured":"Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health. 2006;11:211\u20139.","journal-title":"Trop Med Int Health"},{"key":"2347_CR4","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/j.1365-3156.2006.01690.x","volume":"11","author":"MB Denis","year":"2006","unstructured":"Denis MB, Tsuyuoka R, Poravuth Y, Narann TS, Seila S, Lim C, et al. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health. 2006;11:1360\u20136.","journal-title":"Trop Med Int Health"},{"key":"2347_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"2347_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1475-2875-8-10","volume":"8","author":"WO Rogers","year":"2009","unstructured":"Rogers WO, Sem R, Tero T, Chim P, Lim P, Muth S, et al. Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J. 2009;8:10.","journal-title":"Malar J"},{"key":"2347_CR7","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619\u201320.","journal-title":"N Engl J Med"},{"key":"2347_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"2347_CR9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"2347_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Tracking resistance to artemisinin Collaboration (TRAC): spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"2347_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","volume":"13","author":"B Witkowski","year":"2013","unstructured":"Witkowski B, Amaratunga C, Khim N, Sreng S, Chim P, Kim S, et al. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in vitro and ex vivo drug-response studies. Lancet Infect Dis. 2013;13:1043\u20139.","journal-title":"Lancet Infect Dis"},{"key":"2347_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"2347_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","volume":"347","author":"J Straimer","year":"2015","unstructured":"Straimer J, Gn\u00e4dig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428\u201331.","journal-title":"Science"},{"key":"2347_CR14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","volume":"211","author":"S Takala-Harrison","year":"2015","unstructured":"Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2015;211:670\u20139.","journal-title":"J Infect Dis"},{"key":"2347_CR15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","volume":"15","author":"KM Tun","year":"2015","unstructured":"Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis. 2015;15:415\u201321.","journal-title":"Lancet Infect Dis"},{"key":"2347_CR16","doi-asserted-by":"publisher","first-page":"20100","DOI":"10.1038\/srep20100","volume":"6","author":"R Ye","year":"2016","unstructured":"Ye R, Hu D, Zhang Y, Huang Y, Sun X, Wang J, et al. Distinctive origin of artemisinin-resistant Plasmodium falciparum on the China\u2013Myanmar border. Sci Rep. 2016;6:20100.","journal-title":"Sci Rep"},{"key":"2347_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1475-2875-11-300","volume":"11","author":"W Satimai","year":"2012","unstructured":"Satimai W, Sudathip P, Vijaykadga S, Khamsiriwatchara A, Sawang S, Potithavoranan T, et al. Artemisinin resistance containment project in Thailand. II: responses to mefloquine\u2013artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia. Malar J. 2012;11:300.","journal-title":"Malar J"},{"key":"2347_CR18","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1074\/jbc.272.7.3961","volume":"272","author":"IK Srivastava","year":"1997","unstructured":"Srivastava IK, Rottenberg H, Vaidya AB. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J Biol Chem. 1997;272:3961\u20136.","journal-title":"J Biol Chem"},{"key":"2347_CR19","doi-asserted-by":"publisher","first-page":"17142","DOI":"10.1074\/jbc.M500388200","volume":"280","author":"JJ Kessl","year":"2005","unstructured":"Kessl JJ, Ha KH, Merritt AK, Lange BB, Hill P, Meunier B, et al. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. J Biol Chem. 2005;280:17142\u20138.","journal-title":"J Biol Chem"},{"key":"2347_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2875-2-5","volume":"2","author":"B Schw\u00f6bel","year":"2003","unstructured":"Schw\u00f6bel B, Alifrangis M, Salanti A, Jelinek T. Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker. Malar J. 2003;2:5.","journal-title":"Malar J"},{"key":"2347_CR21","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","volume":"44","author":"M Korsinczky","year":"2000","unstructured":"Korsinczky M, Chen N, Kotecka B, Saul A, Rieckmann K, Cheng Q. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob Agents Chemother. 2000;44:2100\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2347_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976;193:673\u20135.","journal-title":"Science"},{"key":"2347_CR23","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1128\/AAC.16.6.710","volume":"16","author":"RE Desjardins","year":"1979","unstructured":"Desjardins RE, Canfield CJ, Haynes JD, Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother. 1979;16:710\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2347_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0014-4894(92)90180-I","volume":"75","author":"J Wooden","year":"1992","unstructured":"Wooden J, Gould EE, Paull AT, Sibley CH. Plasmodium falciparum: a simple polymerase chain reaction method for differentiating strains. Exp Parasitol. 1992;75:207\u201312.","journal-title":"Exp Parasitol"},{"key":"2347_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimd\u00e9","year":"2001","unstructured":"Djimd\u00e9 A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"2347_CR26","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1046\/j.1365-2958.2000.01914.x","volume":"36","author":"MT Duraisingh","year":"2000","unstructured":"Duraisingh MT, Roper C, Walliker D, Warhurst DC. Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum. Mol Microbiol. 2000;36:955\u201361.","journal-title":"Mol Microbiol"},{"key":"2347_CR27","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","volume":"364","author":"RN Price","year":"2004","unstructured":"Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, et al. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004;364:438\u201347.","journal-title":"Lancet"},{"key":"2347_CR28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JCM.36.1.243-247.1998","volume":"36","author":"J Bickii","year":"1998","unstructured":"Bickii J, Basco LK, Ringwald P. Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates. J Clin Microbiol. 1998;36:243\u20137.","journal-title":"J Clin Microbiol"},{"key":"2347_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/00034983.1994.11812851","volume":"88","author":"LK Basco","year":"1994","unstructured":"Basco LK, Le Bras J. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann Trop Med Parasitol. 1994;88:137\u201344.","journal-title":"Ann Trop Med Parasitol"},{"key":"2347_CR30","first-page":"363","volume":"70","author":"I Hatin","year":"1992","unstructured":"Hatin I, Trape JF, Legros F, Bauchet J, Le Bras J. Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal. Bull World Health Organ. 1992;70:363\u20137.","journal-title":"Bull World Health Organ"},{"key":"2347_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/1475-2875-10-268","volume":"10","author":"B Pradines","year":"2011","unstructured":"Pradines B, Bertaux L, Pomares C, Delaunay P, Marty P. Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia. Malar J. 2011;10:268.","journal-title":"Malar J"},{"key":"2347_CR32","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1016\/j.micinf.2006.07.011","volume":"8","author":"L Musset","year":"2006","unstructured":"Musset L, Bouchaud O, Matheron S, Massias L, Le Bras J. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Microbes Infect. 2006;8:2599\u2013604.","journal-title":"Microbes Infect"},{"key":"2347_CR33","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1128\/AAC.02302-15","volume":"60","author":"DL Saunders","year":"2015","unstructured":"Saunders DL, Chaorattanakawee S, Gosi P, Lanteri C, Somethy S, Kuntawunginn W, et al. Atovaquone-proguanil remains a potential stopgap therapy for multidrug-resistant Plasmodium falciparum in areas along the Thai\u2013Cambodian border. Antimicrob Agents Chemother. 2015;60:1896\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2347_CR34","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/0140-6736(91)92798-7","volume":"337","author":"F Nosten","year":"1991","unstructured":"Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, et al. Mefloquine-resistant falciparum malaria on the Thai\u2013Burmese border. Lancet. 1991;337:1140\u20133.","journal-title":"Lancet"},{"key":"2347_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2875-1-1","volume":"1","author":"QL Fivelman","year":"2002","unstructured":"Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J. 2002;1:1.","journal-title":"Malar J"},{"key":"2347_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1475-2875-7-23","volume":"7","author":"R Khositnithikul","year":"2008","unstructured":"Khositnithikul R, Tan-Ariya P, Mungthin M. In vitro atovaquone\/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand. Malar J. 2008;7:23.","journal-title":"Malar J"},{"key":"2347_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12936-017-1795-y","volume":"16","author":"R Dell\u2019Acqua","year":"2017","unstructured":"Dell\u2019Acqua R, Fabrizio C, Di Gennaro F, Lo Caputo S, Saracino A, Menegon M, et al. An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia. Malar J. 2017;16:149.","journal-title":"Malar J"},{"key":"2347_CR38","volume-title":"Artemisinin and artemisinin-based combination therapy resistance","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Artemisinin and artemisinin-based combination therapy resistance. Geneva: World Health Organization; 2017."},{"key":"2347_CR39","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","volume":"374","author":"D M\u00e9nard","year":"2016","unstructured":"M\u00e9nard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453\u201364.","journal-title":"N Engl J Med"},{"key":"2347_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.actatropica.2005.04.010","volume":"94","author":"TJ Anderson","year":"2005","unstructured":"Anderson TJ, Roper C. The origins and spread of antimalarial drug resistance: lessons for policy makers. Acta Trop. 2005;94:269\u201380.","journal-title":"Acta Trop"},{"key":"2347_CR41","doi-asserted-by":"publisher","first-page":"e1004789","DOI":"10.1371\/journal.ppat.1004789","volume":"11","author":"E Talundzic","year":"2015","unstructured":"Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, et al. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog. 2015;11:e1004789.","journal-title":"PLoS Pathog"},{"key":"2347_CR42","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137.","journal-title":"Lancet Infect Dis"},{"key":"2347_CR43","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/S1473-3099(17)30524-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Hien TT, Thuy-Nhien NT, Dondorp AM, White NJ. Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam. Lancet Infect Dis. 2017;17:1022\u20133.","journal-title":"Lancet Infect Dis"},{"key":"2347_CR44","volume-title":"Single dose primaquine as a gametocyte in Plasmodium falciparum malaria. Updated WHO Policy Recommendation (October 2012)","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Single dose primaquine as a gametocyte in Plasmodium falciparum malaria. Updated WHO Policy Recommendation (October 2012). Geneva: Global Malaria Programme, World Health Organization; 2012."},{"key":"2347_CR45","first-page":"60","volume":"6","author":"S Kitchakarn","year":"2017","unstructured":"Kitchakarn S, Lek D, Thol S, Hok C, Saejeng A, Huy R, et al. Implementation of G6PD testing and primaquine for P. vivax radical cure: operational perspectives from Thailand and Cambodia. WHO South East Asia. J Public Health. 2017;6:60\u20138.","journal-title":"J Public Health"},{"key":"2347_CR46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1128\/AAC.00686-12","volume":"57","author":"R Leang","year":"2013","unstructured":"Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, et al. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008\u20132010. Antimicrob Agents Chemother. 2013;57:818\u201326.","journal-title":"Antimicrob Agents Chemother"},{"key":"2347_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00003495-200565010-00004","volume":"65","author":"TM Davis","year":"2005","unstructured":"Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF. Piperaquine: a resurgent antimalarial drug. Drugs. 2005;65:75\u201387.","journal-title":"Drugs"},{"key":"2347_CR48","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1128\/AAC.01793-10","volume":"55","author":"RT Eastman","year":"2011","unstructured":"Eastman RT, Dharia NV, Winzeler EA, Fidock DA. Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites. Antimicrob Agents Chemother. 2011;55:3908\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"2347_CR49","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1128\/AAC.06350-11","volume":"56","author":"MI Veiga","year":"2012","unstructured":"Veiga MI, Ferreira PE, Malmberg M, J\u00f6rnhagen L, Bj\u00f6rkman A, Nosten F, et al. Pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine. Antimicrob Agents Chemother. 2012;56:3615\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2347_CR50","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1038\/ncomms11553","volume":"7","author":"MI Veiga","year":"2016","unstructured":"Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gn\u00e4dig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.","journal-title":"Nat Commun"},{"key":"2347_CR51","doi-asserted-by":"crossref","first-page":"624","DOI":"10.4269\/ajtmh.16-0668","volume":"96","author":"M Mungthin","year":"2017","unstructured":"Mungthin M, Watanatanasup E, Sitthichot N, Suwandittakul N, Khositnithikul R, Ward SA. Influence of the pfmdr1 gene on in vitro sensitivities of piperaquine in Thai isolates of Plasmodium falciparum. Am J Trop Med Hyg. 2017;96:624\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"2347_CR52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis. 2017;17:164\u201373.","journal-title":"Lancet Infect Dis"},{"key":"2347_CR53","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis. 2017;17:174\u201383.","journal-title":"Lancet Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2347-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-018-2347-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-018-2347-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T14:49:07Z","timestamp":1751640547000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-018-2347-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2347"],"URL":"https:\/\/doi.org\/10.1186\/s12936-018-2347-9","relation":{},"ISSN":["1475-2875"],"issn-type":[{"type":"electronic","value":"1475-2875"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"197"}}